Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered viral vaccines--prospects for the future.

R F Pettersson

    Annals of Clinical Research
    |December 1, 1982
    PubMed
    Summary

    Genetic engineering enables producing valuable proteins and antigens in host cells. This technology shows promise for developing cost-effective vaccines, with early successes in foot-and-mouth disease and hepatitis B.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus.

    Proceedings of the National Academy of Sciences of the United States of America·2008
    Same author

    Endostatin inhibits endochondral ossification.

    The journal of gene medicine·2007
    Same author

    The coxsackie-adenovirus receptor--a new receptor in the immunoglobulin family involved in cell adhesion.

    Current topics in microbiology and immunology·2003
    Same author

    [Hartwell, Hunt and Nurse share the 2001 Nobel Prize in physiology or medicine. CDK and cyclin--molecular motors of cell cycle].

    Lakartidningen·2001
    Same author

    Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.

    International immunology·2001
    Same author

    Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.

    Journal of virology·2001

    Area of Science:

    • Molecular Biology
    • Biotechnology
    • Vaccinology

    Background:

    • Genetic engineering, or recombinant DNA technology, allows gene isolation and transfer between cells.
    • This facilitates the production of commercially valuable proteins and antigens in microbial hosts like bacteria and yeast.

    Purpose of the Study:

    • To explore the potential of genetic engineering for the cost-effective manufacturing of vaccines.
    • To review the progress and challenges in developing genetically engineered viral vaccines.

    Main Methods:

    • Isolation and purification of specific genes.
    • Cloning genes into expression vectors.
    • Transformation of host cells (bacteria, yeast) with recombinant DNA.
    • Expression of foreign genes to produce proteins/antigens.

    Main Results:

    • Successful production of commercially valuable proteins (hormones, enzymes).
    • Production of viral and bacterial antigens demonstrated.
    • Development of a foot-and-mouth disease virus vaccine reported as a promising example.
    • Expression of hepatitis B surface antigen, influenza virus haemagglutinin, and poliovirus proteins achieved.

    Conclusions:

    • Genetic engineering offers a powerful platform for vaccine development.
    • Significant progress has been made, but technical and immunological challenges remain.
    • Further research is crucial for the clinical application of safe and effective genetically engineered viral vaccines.

    Related Experiment Videos